Johnson & Johnson (JNJ)
205.34
-1.58 (-0.76%)
NYSE · Last Trade: Dec 2nd, 1:40 AM EST
As December 2025 dawns, global financial markets are gripped by a palpable "risk-off" sentiment, erasing much of November's robust gains and signaling a cautious start to the month. This widespread retreat from speculative assets is largely driven by a confluence of factors, including surging global Treasury yields, particularly in the
Via MarketMinute · December 1, 2025
The financial markets have opened December on a cautious note, experiencing a notable downturn that has seen major indexes—the Dow Jones Industrial Average (DJIA), S&P 500, and Nasdaq Composite—all retreat. This sudden shift marks a stark contrast to the robust rebound witnessed throughout November, signaling a pervasive
Via MarketMinute · December 1, 2025
As of late 2025, Artificial Intelligence (AI) is rapidly emerging as a transformative "substitute teacher" in medical education, fundamentally reshaping how aspiring surgeons acquire and refine their skills. This groundbreaking integration of AI, particularly in coaching surgical techniques, carries immediate and profound implications for the healthcare landscape, offering a potent solution to the persistent and [...]
Via TokenRing AI · December 1, 2025
Via MarketBeat · December 1, 2025
December 1, 2025, has dawned with a distinct chill across global financial markets, as major indices including the Dow Jones Industrial Average (NYSE: ^DJI), S&P 500 (NYSE: ^GSPC), and Nasdaq Composite (NASDAQ: ^IXIC) experienced significant declines, signaling a somber commencement to the final month of the year. Adding to
Via MarketMinute · December 1, 2025
New York, NY – December 1, 2025 – The S&P 500 has begun December 2025 with a notable decline, signaling a profound shift in market sentiment as investors grapple with a confluence of challenging economic factors. This downturn, described by analysts as "rediscovering gravity," comes after a period of sustained upward
Via MarketMinute · December 1, 2025
If you buy companies with in-demand products and hold for the long term, you can end up with long-term winners.
Via The Motley Fool · November 30, 2025
Patience will be rewarded for those who stick with these two healthcare stocks.
Via The Motley Fool · November 30, 2025
The Dow Jones Industrial Average (DJIA) has staged a remarkable comeback, successfully erasing its November 2025 losses by the month's final trading day, Friday, November 28, 2025. This significant recovery not only marked a powerful late-month surge but also extended the index's impressive streak of monthly gains to seven, injecting
Via MarketMinute · November 28, 2025
The financial markets in late 2025 are signaling a significant, albeit cautious, shift away from the concentrated leadership that has defined much of the past two years. For an extended period, market gains were predominantly driven by a select cohort of mega-cap technology companies, often dubbed the "Magnificent Seven," largely
Via MarketMinute · November 28, 2025
Johnson & Johnson has outpaced the S&P 500 over the past year, and analysts remain optimistic about the healthcare stock's growth potential ahead.
Via Barchart.com · November 28, 2025
Dividends can help enrich your portfolio for years to come.
Via The Motley Fool · November 27, 2025
These top dividend stocks could intrigue a wide range of investors.
Via The Motley Fool · November 27, 2025
Johnson & Johnson stock rises on strong earnings, the Halda deal, FDA wins and an upcoming orthopedics spinoff as analysts weigh the outlook.
Via Benzinga · November 26, 2025
Johnson & Johnson ends its Phase 2b posdinemab trial after missing key Alzheimer's goals, raising concerns for next-generation tau-targeting drug programs.
Via Benzinga · November 25, 2025
The financial markets are currently navigating a turbulent sea of uncertainty, grappling with the profound implications of significantly delayed economic reports. As of November 25, 2025, the aftershocks of a recent 43-day U.S. government shutdown, which concluded on November 12th, have created an unprecedented "information vacuum." This scarcity of
Via MarketMinute · November 25, 2025
The financial markets are grappling with unprecedented uncertainty following the U.S. data agency's cancellation of the October Consumer Price Index (CPI) report. This unexpected data void has left the Federal Reserve without a crucial gauge of inflation, significantly complicating its ongoing deliberations regarding potential interest rate adjustments and introducing
Via MarketMinute · November 21, 2025
The US stock market has just concluded a tumultuous week, characterized by extreme volatility and pronounced "whipsaw" movements across its major indices. From November 14th to November 21st, 2025, investors witnessed rapid and unpredictable swings in the Dow Jones Industrial Average (DJIA), the Nasdaq Composite (NASDAQ), and the S&P
Via MarketMinute · November 21, 2025
A spate of promising news is helping to extend a post-earnings rally for the healthcare giant's shares.
Via The Motley Fool · November 21, 2025
The long-awaited September 2025 Jobs Report, finally released on November 20, 2025, after a significant federal government shutdown delay, has unveiled a complex and contradictory landscape for the U.S. labor market. While the economy demonstrated a surprising resilience with continued job creation that outpaced expectations, the report simultaneously highlighted
Via MarketMinute · November 20, 2025
November 20, 2025, witnessed a dramatic turn of events in the financial markets, as the much-touted "AI High-Flyers" and a broad swathe of "Speculative Trades" experienced a stunning reversal, erasing earlier gains and plunging into a significant sell-off. What began as another day of robust optimism and upward momentum for
Via MarketMinute · November 20, 2025
Nvidia (NASDAQ: NVDA), the undisputed titan of the artificial intelligence (AI) chip market, experienced a dramatic and unsettling reversal on November 20, 2025, with its stock "turning red" and closing significantly lower despite reporting blowout third-quarter fiscal 2026 earnings. After an initial surge that saw shares climb as much as
Via MarketMinute · November 20, 2025
WASHINGTON D.C. – November 20, 2025 – After a significant delay caused by a 43-day federal government shutdown, the September 2025 jobs report was finally released today, painting a complex picture of the U.S. labor market. The report, initially due on October 3rd, offers a belated but crucial snapshot, revealing
Via MarketMinute · November 20, 2025
New York, NY – November 20, 2025 – UBS Group has adjusted its outlook on Medtronic plc (NYSE: MDT) stock, raising its price target to $102.00 from $95.00. This upward revision follows Medtronic's stronger-than-expected second-quarter fiscal 2026 earnings report, which showcased robust performance driven by key segments and innovative technology.
Via MarketMinute · November 20, 2025
As November 2025 unfolds, the financial markets find themselves in a delicate balance, with gold demonstrating remarkable resilience and even significant appreciation, while global stock markets grapple with persistent jitters. This dynamic environment is further complicated by a deeply divided Federal Reserve, whose uncertain path on interest rate cuts continues
Via MarketMinute · November 19, 2025
